{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:13:38Z","timestamp":1786115618392,"version":"build-2736575974"},"reference-count":83,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>XueFuZhuYu pills (XFZY), a traditional Chinese herbal formula originated\nfrom the xuefuzhuyu decoction in Correction on Errors in Medical Classics, has a certain\nclinical effect on the treatment of hyperprolactinemia (HPRL) caused by antipsychotics. However,\nthe active ingredients and mechanism by which XFZY contributes to the hyperprolactinemia\ncaused by antipsychotics remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The aim of the study was to investigate the molecular basis of XFZY in the therapy\nof antipsychotic-induced HPRL and to establish a scientific foundation for its application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>First, the UHPLC-Q-TOF-MS\/MS methodology was employed to perform chromatographic\nseparation and gather mass spectrometry data. Subsequently, the preprocessed mass\nspectrometry data were uploaded to the Global Natural Products Social Molecular Networking\n(GNPS) platform for spectral library interrogation and molecular network analysis. Next, based\non the detected chemical constituents and the Traditional Chinese Medicine Systems Pharmacology\n(TCMSP) database, the effective chemical components within XFZY were chosen.\nSwiss Target Prediction was employed to determine probable targets of components, and we\nused Cytoscape to create a network of components and their associated targets. After that,\nHPRL-related targets were found and filtered using four disease databases, and then a proteinprotein\ninteraction (PPI) network was built using the STRING database. Cytoscape was utilized\nto conduct visualization and cluster analysis. Meanwhile, the Metascape database was adopted\nfor the enrichment analysis of GO and KEGG. At last, Autodock Vina was applied to perform\nmolecular docking between the principal components and target proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In total, 213 compounds were discovered in XFZY. Two hundred eight active chemical\ncomponents, 622 probable targets, and 242 HPRL-related target genes were identified. There\nwere 76 common targets between the XFZY and HPRL. Following analysis, 1371 GO biological\nprocess items and 162 KEGG signal pathways were identified. The primary chemicals and\ntarget proteins exhibited great affinity in molecular docking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>These findings reveal that XFZY exerts anti-hyperprolactinemia effects through\nmulti-component, multi-target, and multi-pathway synergistic regulatory mechanisms, providing\na scientific basis for its clinical application in antipsychotic-induced HPRL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This research manifests that XFZY, as a traditional Chinese medicine formula,\nproffers a novel pathway for the treatment of antipsychotic-induced HPRL. We elucidated the\nspecific molecular mechanisms underlying the anti-HPRL effects of XFZY and its active ingredients,\nlaying a foundation for the subsequent clinical applications of this formula.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734099366667250410061157","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:52:08Z","timestamp":1745819528000},"page":"282-302","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Active Ingredients and Mechanisms of Xuefuzhuyu Pills in Treating Hyperprolactinemia Caused by Antipsychotics based on UHPLCQ-TOF-MS\/MS, Network Pharmacology, and Molecular Docking Validation"],"prefix":"10.2174","volume":"22","author":[{"given":"Linliu","family":"Du","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, PRChina"},{"name":"Hebei Medical University, Shijiazhuang, 050017, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, PRChina"},{"name":"Hebei Medical University, Shijiazhuang, 050017, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, PRChina"},{"name":"Hebei Medical University, Shijiazhuang, 050017, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanli","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, PRChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, PRChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, PRChina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1136\/jim-2022-002351","volume":"70","author":"Ghoreshi Z.","year":"2022","unstructured":"Ghoreshi Z.; Akbari H.; Sharif-zak M.; Arefinia N.; Abbasi-Jorjandi M.; Asadikaram G.; Recent findings on hyperprolactinemia and its pathological implications: A literature review. J Investig Med  2022,70(7),1443-1451","journal-title":"J Investig Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"101324","DOI":"10.1016\/j.beem.2019.101324","volume":"33","author":"Borba V.V.","year":"2019","unstructured":"Borba V.V.; Zandman-Goddard G.; Shoenfeld Y.; Prolactin and autoimmunity: The hormone as an inflammatory cytokine. Best Pract Res Clin Endocrinol Metab  2019,33(6),101324","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1055\/s-0043-107243","volume":"49","author":"Krogh J.","year":"2017","unstructured":"Krogh J.; Selmer C.; Torp-Pedersen C.; Gislason G.; Kistorp C.; Hyperprolactinemia and the association with all-cause mortality and cardiovascular mortality. Horm Metab Res  2017,49(6),411-417","journal-title":"Horm Metab Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s40263-021-00812-1","volume":"35","author":"Besag F.M.C.","year":"2021","unstructured":"Besag F.M.C.; Vasey M.J.; Salim I.; Is adjunct aripiprazole effective in treating hyperprolactinemia induced by psychotropic medication? A narrative review. CNS Drugs  2021,35(5),507-526","journal-title":"CNS Drugs"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"681418","DOI":"10.3389\/fpsyt.2021.681418","volume":"12","author":"Zhuo C.","year":"2021","unstructured":"Zhuo C.; Xu Y.; Wang H.; Fang T.; Chen J.; Zhou C.; Li Q.; Liu J.; Xu S.; Yao C.; Yang W.; Yang A.; Li B.; Chen Y.; Tian H.; Lin C.; Safety and efficacy of high-dose vitamin B6 as an adjunctive treatment for antipsychotic-induced hyperprolactinemia in male patients with treatment-resistant schizophrenia. Front Psychiatry  2021,12(12),681418","journal-title":"Front Psychiatry"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1517\/17425255.2013.791283","volume":"9","author":"Voicu V.","year":"2013","unstructured":"Voicu V.; Medvedovici A.; Ranetti A.E.; R\u0103dulescu F.\u015e.; Drug-induced hypo- and hyperprolactinemia: Mechanisms, clinical and therapeutic consequences. Expert Opin Drug Metab Toxicol  2013,9(8),955-968","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=7","doi-asserted-by":"crossref","DOI":"10.61622\/rbgo\/2024FPS04","volume":"46","author":"Glezer A","year":"2024","unstructured":"Glezer A; Garmes HM; Kasuki L; Martins M; Elias P; Nogueira V; Hyperprolactinemia in women: Diagnostic approach Rev Bras Ginecol Obstet  2024,46","journal-title":"Rev Bras Ginecol Obstet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ajhp\/zxab065","volume":"78","author":"Rusgis M.M.","year":"2021","unstructured":"Rusgis M.M.; Alabbasi A.Y.; Nelson L.A.; Guidance on the treatment of antipsychotic-induced hyperprolactinemia when switching the antipsychotic is not an option. Am J Health Syst Pharm  2021,78(10),862-871","journal-title":"Am J Health Syst Pharm"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.schres.2020.04.031","volume":"222","author":"Labad J.","year":"2020","unstructured":"Labad J.; Montalvo I.; Gonz\u00e1lez-Rodr\u00edguez A.; Garc\u00eda-Rizo C.; Crespo-Facorro B.; Monreal J.A.; Palao D.; Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysis. Schizophr Res  2020,222(222),88-96","journal-title":"Schizophr Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e230504","DOI":"10.20945\/2359-4292-2023-0504","volume":"68","author":"Benetti-Pinto C.L.","year":"2024","unstructured":"Benetti-Pinto C.L.; N\u00e1cul A.P.; Rosa-e-Silva A.C.J.S.; Maciel G.A.R.; Nogueira V.S.N.; Elias P.C.L.; Martins M.; Kasuki L.; Garmes H.M.; Glezer A.; Treatment of hyperprolactinemia in women: A position statement from the Brazilian federation of gynecology and obstetrics associations (Febrasgo) and the Brazilian society of endocrinology and metabolism (SBEM). Arch Endocrinol Metab  2024,68,e230504","journal-title":"Arch Endocrinol Metab"},{"key":"ref=11","first-page":"3519","volume":"34","author":"Gao Y.","year":"2021","unstructured":"Gao Y.; Shen L.; Yan H.; Clinical research progress of hyperprolactinemia caused by antipsychotics. J Med Theory Pract  2021,34(20),3519-3520","journal-title":"J Med Theory Pract"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12885-023-11789-z","volume":"24","author":"Wang R.","year":"2024","unstructured":"Wang R.; Wang Y.; Fang L.; Xie Y.; Yang S.; Liu S.; Fang Y.; Zhang Y.; Efficacy and safety of traditional Chinese medicine in the treatment of menopause-like syndrome for breast cancer survivors: A systematic review and meta-analysis. BMC Cancer  2024,24(1),42","journal-title":"BMC Cancer"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"100850","DOI":"10.1016\/j.hermed.2024.100850","volume":"44","author":"Jin H.","year":"2024","unstructured":"Jin H.; Dai L.; Yi Y.; Wang Q.; Cai C.; Cai C.; Effectiveness of traditional Chinese medicine with liver-soothing function for hyperplasia of mammary glands: A systematic review and meta-analysis. J Herb Med  2024,44,100850","journal-title":"J Herb Med"},{"key":"ref=14","first-page":"893","volume":"7","author":"Li Y.X.","year":"2014","unstructured":"Li Y.X.; Progress in treatment based on syndrome differentiation of traditional Chinese medicine for hyperprolactinemia caused by antipsychotic drugs. Glob Tradit Chin Med  2014,7(11),893-896","journal-title":"Glob Tradit Chin Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7182865","volume":"2019","author":"Chen G.","year":"2019","unstructured":"Chen G.; He H.; Hu K.; Gao J.; Li J.; Han M.; Wang J.; Sensitive biomarker analysis of Xue-Fu-Zhu-Yu capsule for patients with Qi stagnation and blood stasis pattern: A nested case-control study. Evid Based Complement Alternat Med  2019,2019,1-12","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=16","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-184004\/v1","author":"Li H.","year":"2021","unstructured":"Li H.; Wu H.; Li W.; Yang J.; Wei P.; Anti-inflammatory mechanisms of Xuefu Zhuyu decoction in the treatment of atherosclerosis based on network pharmacology and microarray data differences analysis. Research Square  2021","journal-title":"Research Square"},{"key":"ref=17","first-page":"34","volume":"54","author":"Lin L.","year":"2022","unstructured":"Lin L.; Wang Y.; Yuan H.; Clinical study on Xuefu Zhuyu Tang for risperidone-induced hyperprolactinemia in female schizophrenia. New Chinese Medicine  2022,54(19),34-38","journal-title":"New Chinese Medicine"},{"key":"ref=18","first-page":"38","volume":"8","author":"Liu L.F.","year":"2021","unstructured":"Liu L.F.; Clinical study of Xuefu Zhuyu tablet in the treatment of female patients with hyperprolactinemia caused by antipsychotic drugs. Electron J Pract Gynecol Endocrinol  2021,8(16),38-40","journal-title":"Electron J Pract Gynecol Endocrinol"},{"key":"ref=19","first-page":"20","volume":"23","author":"Liu D.","year":"2017","unstructured":"Liu D.; Xu F.; Ma J.; Meng H.; Xu M.; Clinical study on Xuefu Zhuyu decoction in the treatment of hyperprolactinemia caused by antipsychotics. J Clin Psychosom Dis  2017,23(01),20-22","journal-title":"J Clin Psychosom Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1503\/jpn.140009","volume":"41","author":"Wang H.","year":"2016","unstructured":"Wang H.; Liang S.; Wang M.; Gao J.; Sun C.; Wang J.; Xia W.; Wu S.; Sumner S.J.; Zhang F.; Sun C.; Wu L.; Potential serum biomarkers from a metabolomics study of autism. J Psychiatry Neurosci  2016,41(1),27-37","journal-title":"J Psychiatry Neurosci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1556\/1326.2019.00688","volume":"32","author":"Shao S.Y.","year":"2020","unstructured":"Shao S.Y.; Ting Y.; Wang J.; Sun J.; Guo X.F.; Characterization and identification of the major flavonoids in Phyllostachys edulis leaf extract by UPLC\u2013QTOF\u2013MS\/MS. Acta Chromatogr  2020,32(4),228-237","journal-title":"Acta Chromatogr"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1038\/s41467-021-23953-9","volume":"12","author":"Schmid R.","year":"2021","unstructured":"Schmid R.; Petras D.; Nothias L.F.; Wang M.; Aron A.T.; Jagels A.; Tsugawa H.; Rainer J.; Garcia-Aloy M.; D\u00fchrkop K.; Korf A.; Pluskal T.; Kamen\u00edk Z.; Jarmusch A.K.; Caraballo-Rodr\u00edguez A.M.; Weldon K.C.; Nothias-Esposito M.; Aksenov A.A.; Bauermeister A.; Albarracin Orio A.; Grundmann C.O.; Vargas F.; Koester I.; Gauglitz J.M.; Gentry E.C.; H\u00f6velmann Y.; Kalinina S.A.; Pendergraft M.A.; Panitchpakdi M.; Tehan R.; Le Gouellec A.; Aleti G.; Mannochio Russo H.; Arndt B.; H\u00fcbner F.; Hayen H.; Zhi H.; Raffatellu M.; Prather K.A.; Aluwihare L.I.; B\u00f6cker S.; McPhail K.L.; Humpf H.U.; Karst U.; Dorrestein P.C.; Ion identity molecular networking for mass spectrometry-based metabolomics in the GNPS environment. Nat Commun  2021,12(1),3832","journal-title":"Nat Commun"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41592-020-0933-6","volume":"17","author":"Nothias L.F.","year":"2020","unstructured":"Nothias L.F.; Petras D.; Schmid R.; D\u00fchrkop K.; Rainer J.; Sarvepalli A.; Protsyuk I.; Ernst M.; Tsugawa H.; Fleischauer M.; Aicheler F.; Aksenov A.A.; Alka O.; Allard P.M.; Barsch A.; Cachet X.; Caraballo-Rodriguez A.M.; Da Silva R.R.; Dang T.; Garg N.; Gauglitz J.M.; Gurevich A.; Isaac G.; Jarmusch A.K.; Kamen\u00edk Z.; Kang K.B.; Kessler N.; Koester I.; Korf A.; Le Gouellec A.; Ludwig M.; Martin H.; C.; McCall, L.I.; McSayles, J.; Meyer, S.W.; Mohimani, H.; Morsy, M.; Moyne, O.; Neumann, S.; Neuweger, H.; Nguyen, N.H.; Nothias-Esposito, M.; Paolini, J.; Phelan, V.V.; Pluskal, T.; Quinn, R.A.; Rogers, S.; Shrestha, B.; Tripathi, A.; van der Hooft, J.J.J.; Vargas, F.; Weldon, K.C.; Witting, M.; Yang, H.; Zhang, Z.; Zubeil, F.; Kohlbacher, O.; B\u00f6cker, S.; Alexandrov, T.; Bandeira, N.; Wang, M.; Dorrestein, P.C. Feature-based molecular networking in the GNPS analysis environment. Nat Methods  2020,17(9),905-908","journal-title":"Nat Methods"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nbt.3597","volume":"34","author":"Wang M.","year":"2016","unstructured":"Wang M.; Carver J.J.; Phelan V.V.; Sanchez L.M.; Garg N.; Peng Y.; Nguyen D.D.; Watrous J.; Kapono C.A.; Luzzatto-Knaan T.; Porto C.; Bouslimani A.; Melnik A.V.; Meehan M.J.; Liu W.T.; Cr\u00fcsemann M.; Boudreau P.D.; Esquenazi E.; Sandoval-Calder\u00f3n M.; Kersten R.D.; Pace L.A.; Quinn R.A.; Duncan K.R.; Hsu C.C.; Floros D.J.; Gavilan R.G.; Kleigrewe K.; Northen T.; Dutton R.J.; Parrot D.; Carlson E.E.; Aigle B.; Michelsen C.F.; Jelsbak L.; Sohlenkamp C.; Pevzner P.; Edlund A.; McLean J.; Piel J.; Murphy B.T.; Gerwick L.; Liaw C.C.; Yang Y.L.; Humpf H.U.; Maansson M.; Keyzers R.A.; Sims A.C.; Johnson A.R.; Sidebottom A.M.; Sedio B.E.; Klitgaard A.; Larson C.B.; Boya P.; C.A.; Torres-Mendoza, D.; Gonzalez, D.J.; Silva, D.B.; Marques, L.M.; Demarque, D.P.; Pociute, E.; O\u2019Neill, E.C.; Briand, E.; Helfrich, E.J.N.; Granatosky, E.A.; Glukhov, E.; Ryffel, F.; Houson, H.; Mohimani, H.; Kharbush, J.J.; Zeng, Y.; Vorholt, J.A.; Kurita, K.L.; Charusanti, P.; McPhail, K.L.; Nielsen, K.F.; Vuong, L.; Elfeki, M.; Traxler, M.F.; Engene, N.; Koyama, N.; Vining, O.B.; Baric, R.; Silva, R.R.; Mascuch, S.J.; Tomasi, S.; Jenkins, S.; Macherla, V.; Hoffman, T.; Agarwal, V.; Williams, P.G.; Dai, J.; Neupane, R.; Gurr, J.; Rodr\u00edguez, A.M.C.; Lamsa, A.; Zhang, C.; Dorrestein, K.; Duggan, B.M.; Almaliti, J.; Allard, P.M.; Phapale, P.; Nothias, L.F.; Alexandrov, T.; Litaudon, M.; Wolfender, J.L.; Kyle, J.E.; Metz, T.O.; Peryea, T.; Nguyen, D.T.; VanLeer, D.; Shinn, P.; Jadhav, A.; M\u00fcller, R.; Waters, K.M.; Shi, W.; Liu, X.; Zhang, L.; Knight, R.; Jensen, P.R.; Palsson, B.\u00d8.; Pogliano, K.; Linington, R.G.; Guti\u00e9rrez, M.; Lopes, N.P.; Gerwick, W.H.; Moore, B.S.; Dorrestein, P.C.; Bandeira, N. Sharing and community curation of mass spectrometry data with global natural products social molecular networking. Nat Biotechnol  2016,34(8),828-837","journal-title":"Nat Biotechnol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/s41596-020-0317-5","volume":"15","author":"Aron A.T.","year":"2020","unstructured":"Aron A.T.; Gentry E.C.; McPhail K.L.; Nothias L.F.; Nothias-Esposito M.; Bouslimani A.; Petras D.; Gauglitz J.M.; Sikora N.; Vargas F.; van der Hooft J.J.J.; Ernst M.; Kang K.B.; Aceves C.M.; Caraballo-Rodr\u00edguez A.M.; Koester I.; Weldon K.C.; Bertrand S.; Roullier C.; Sun K.; Tehan R.M.; Boya P.; C.A.; Christian, M.H.; Guti\u00e9rrez, M.; Ulloa, A.M.; Tejeda Mora, J.A.; Mojica-Flores, R.; Lakey-Beitia, J.; V\u00e1squez-Chaves, V.; Zhang, Y.; Calder\u00f3n, A.I.; Tayler, N.; Keyzers, R.A.; Tugizimana, F.; Ndlovu, N.; Aksenov, A.A.; Jarmusch, A.K.; Schmid, R.; Truman, A.W.; Bandeira, N.; Wang, M.; Dorrestein, P.C. Reproducible molecular networking of untargeted mass spectrometry data using GNPS. Nat Protoc  2020,15(6),1954-1991","journal-title":"Nat Protoc"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.tips.2016.10.011","volume":"38","author":"Quinn R.A.","year":"2017","unstructured":"Quinn R.A.; Nothias L.F.; Vining O.; Meehan M.; Esquenazi E.; Dorrestein P.C.; Molecular networking as a drug discovery, drug metabolism, and precision medicine strategy. Trends Pharmacol Sci  2017,38(2),143-154","journal-title":"Trends Pharmacol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"578346","DOI":"10.3389\/fphar.2020.578346","volume":"11","author":"Houriet J.","year":"2020","unstructured":"Houriet J.; Allard P.M.; Queiroz E.F.; Marcourt L.; Gaudry A.; Vallin L.; Li S.; Lin Y.; Wang R.; Kuchta K.; Wolfender J.L.; A mass spectrometry based metabolite profiling workflow for selecting abundant specific markers and their structurally related multi-component signatures in traditional chinese medicine multi\u2010herb formulae. Front Pharmacol  2020,11(11),578346","journal-title":"Front Pharmacol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-1-4939-6747-6_23","volume":"1550","author":"Adusumilli R.","year":"2017","unstructured":"Adusumilli R.; Mallick P.; Data conversion with proteowizard msconvert. Methods Mol Biol  2017,1550(1550),339-368","journal-title":"Methods Mol Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"8696","DOI":"10.1021\/acs.analchem.7b00947","volume":"89","author":"Myers O.D.","year":"2017","unstructured":"Myers O.D.; Sumner S.J.; Li S.; Barnes S.; Du X.; One step forward for reducing false positive and false negative compound identifications from mass spectrometry metabolomics data: New algorithms for constructing extracted ion chromatograms and detecting chromatographic peaks. Anal Chem  2017,89(17),8696-8703","journal-title":"Anal Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11655-019-3064-0","volume":"26","author":"Luo T.","year":"2020","unstructured":"Luo T.; Lu Y.; Yan S.; Xiao X.; Rong X.; Guo J.; Network pharmacology in research of chinese medicine formula: Methodology, application and prospective. Chin J Integr Med  2020,26(1),72-80","journal-title":"Chin J Integr Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/nbt1007-1110","volume":"25","author":"Hopkins A.L.","year":"2007","unstructured":"Hopkins A.L.; Network pharmacology. Nat Biotechnol  2007,25(10),1110-1111","journal-title":"Nat Biotechnol"},{"key":"ref=32","first-page":"479","volume":"42","author":"Jiashuo W.U.","year":"2022","unstructured":"Jiashuo W.U.; Fangqing Z.; Zhuangzhuang L.I.; Weiyi J.; Yue S.; Integration strategy of network pharmacology in Traditional Chinese Medicine: A narrative review. J Tradit Chin Med  2022,42(3),479-486","journal-title":"J Tradit Chin Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O.; Olson A.J.; AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem  2010,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jep.2012.01.041","volume":"140","author":"Barlow D.J.","year":"2012","unstructured":"Barlow D.J.; Buriani A.; Ehrman T.; Bosisio E.; Eberini I.; Hylands P.J.; In-silico studies in Chinese herbal medicines\u2019 research: Evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date. J Ethnopharmacol  2012,140(3),526-534","journal-title":"J Ethnopharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","volume":"11","author":"Pluskal T.","year":"2010","unstructured":"Pluskal T.; Castillo S.; Villar-Briones A.; Ore\u0161i\u010d M.; MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics  2010,11(1),395","journal-title":"BMC Bioinformatics"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"7905","DOI":"10.1007\/s00216-016-9919-8","volume":"408","author":"Hu M.","year":"2016","unstructured":"Hu M.; Krauss M.; Brack W.; Schulze T.; Optimization of LC-Orbitrap-HRMS acquisition and MZmine 2 data processing for nontarget screening of environmental samples using design of experiments. Anal Bioanal Chem  2016,408(28),7905-7915","journal-title":"Anal Bioanal Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/metabo11110763","volume":"11","author":"Ramabulana A.T.","year":"2021","unstructured":"Ramabulana A.T.; Petras D.; Madala N.E.; Tugizimana F.; Metabolomics and molecular networking to characterize the chemical space of four Momordica plant species. Metabolites  2021,11(11),763","journal-title":"Metabolites"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jep.2018.12.033","volume":"233","author":"Li B.","year":"2019","unstructured":"Li B.; Rui J.; Ding X.; Yang X.; Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy. J Ethnopharmacol  2019,233(233),158-168","journal-title":"J Ethnopharmacol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"743494","DOI":"10.3389\/fphar.2021.743494","volume":"12","author":"Hongkaew Y.","year":"2021","unstructured":"Hongkaew Y.; Gaedigk A.; Wilffert B.; Gaedigk R.; Kittitharaphan W.; Ngamsamut N.; Limsila P.; Puangpetch A.; Sukprasong R.; Sukasem C.; Pharmacogenomics factors influencing the effect of risperidone on prolactin levels in Thai pediatric patients with autism spectrum disorder. Front Pharmacol  2021,12(12),743494","journal-title":"Front Pharmacol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/13651501.2022.2050259","volume":"26","author":"Coronel D.A.","year":"2022","unstructured":"Coronel D.A.; De la Pe\u00f1a F.R.; Palacios-Cruz L.; Cuevas D.; Duran S.; Sociodemographic and clinical characteristics related with hyperprolactinaemia in psychiatric clinical population. Int J Psychiatry Clin Pract  2022,26(4),387-394","journal-title":"Int J Psychiatry Clin Pract"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/schbul\/sbab078","volume":"47","author":"Neumeier M.S.","year":"2021","unstructured":"Neumeier M.S.; Homan S.; Vetter S.; Seifritz E.; Kane J.M.; Huhn M.; Leucht S.; Homan P.; Examining side effect variability of antipsychotic treatment in schizophrenia spectrum disorders: A meta-analysis of variance. Schizophr Bull  2021,47(6),1601-1610","journal-title":"Schizophr Bull"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4103\/0974-1208.121400","volume":"6","author":"Majumdar A.","year":"2013","unstructured":"Majumdar A.; Mangal N.; Hyperprolactinemia. J Hum Reprod Sci  2013,6(3),168-175","journal-title":"J Hum Reprod Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/YIC.0b013e328341e434","volume":"26","author":"Serretti A.","year":"2011","unstructured":"Serretti A.; Chiesa A.; A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol  2011,26(3),130-140","journal-title":"Int Clin Psychopharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1111\/j.1743-6109.2010.01709.x","volume":"7","author":"Montejo \u00c1.L.","year":"2010","unstructured":"Montejo \u00c1.L.; Majadas S.; Rico-Villademoros F.; LLorca, G.; De La G\u00e1ndara, J.; Franco, M.; Mart\u00edn-Carrasco, M.; Aguera, L.; Prieto, N. Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics. J Sex Med  2010,7(10),3404-3413","journal-title":"J Sex Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/S0924-9338(10)71700-4","volume":"25","author":"Heald A.","year":"2010","unstructured":"Heald A.; Physical health in schizophrenia: A challenge for antipsychotic therapy. Eur Psychiatry  2010,25(S2)(Suppl. 2),S6-S11","journal-title":"Eur Psychiatry"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.eurpsy.2004.06.031","volume":"19","author":"Lambert M.","year":"2004","unstructured":"Lambert M.; Conus P.; Eide P.; Mass R.; Karow A.; Moritz S.; Golks D.; Naber D.; Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry  2004,19(7),415-422","journal-title":"Eur Psychiatry"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.schres.2018.02.051","volume":"199","author":"Cavelti M.","year":"2018","unstructured":"Cavelti M.; Kircher T.; Nagels A.; Strik W.; Homan P.; Is formal thought disorder in schizophrenia related to structural and functional aberrations in the language network? A systematic review of neuroimaging findings. Schizophr Res  2018,199(199),2-16","journal-title":"Schizophr Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pscychresns.2018.05.011","volume":"279","author":"Cavelti M.","year":"2018","unstructured":"Cavelti M.; Winkelbeiner S.; Federspiel A.; Walther S.; Stegmayer K.; Giezendanner S.; Laimb\u00f6ck K.; Dierks T.; Strik W.; Horn H.; Homan P.; Formal thought disorder is related to aberrations in language-related white matter tracts in patients with schizophrenia. Psychiatry Res Neuroimaging  2018,279(279),40-50","journal-title":"Psychiatry Res Neuroimaging"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.schres.2018.06.009","volume":"201","author":"Winkelbeiner S.","year":"2018","unstructured":"Winkelbeiner S.; Cavelti M.; Federspiel A.; Kunzelmann K.; Dierks T.; Strik W.; Horn H.; Homan P.; Decreased blood flow in the right insula and middle temporal gyrus predicts negative formal thought disorder in schizophrenia. Schizophr Res  2018,201(201),432-434","journal-title":"Schizophr Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"CD006617","DOI":"10.1002\/14651858.CD006617.pub3","volume":"2014","author":"Bhattacharjee J.","year":"2008","unstructured":"Bhattacharjee J.; El-Sayeh H.G.; Aripiprazole versus typical antipsychotic drugs for schizophrenia. Cochrane Libr  2008,2014(7),CD006617","journal-title":"Cochrane Libr"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0165-1781(02)00022-7","volume":"109","author":"Zhang X.Y.","year":"2002","unstructured":"Zhang X.Y.; Zhou D.F.; Yuan C.L.; Zhang P.Y.; Wu G.Y.; Shen Y.C.; Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia. Psychiatry Res  2002,109(3),297-302","journal-title":"Psychiatry Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"558474","DOI":"10.3389\/fphar.2020.558474","volume":"11","author":"Baeza-Flores G.D.C.","year":"2020","unstructured":"Baeza-Flores G.D.C.; Guzm\u00e1n-Priego C.G.; Parra-Flores L.I.; Murbarti\u00e1n J.; Torres-L\u00f3pez J.E.; Granados-Soto V.; Metformin: A prospective alternative for the treatment of chronic pain. Front Pharmacol  2020,11(11),558474","journal-title":"Front Pharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"105904","DOI":"10.1016\/j.dib.2020.105904","volume":"31","author":"Labad J.","year":"2020","unstructured":"Labad J.; Montalvo I.; Gonz\u00e1lez-Rodr\u00edguez A.; Garc\u00eda-Rizo C.; Crespo-Facorro B.; Monreal J.A.; Palao D.; Data of a meta-analysis on pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia. Data Brief  2020,31(31),105904","journal-title":"Data Brief"},{"key":"ref=54","first-page":"168","volume":"16","author":"Dong Z.","year":"2020","unstructured":"Dong Z.; Zhang T.; Li Y.; Wan J.; Meta analysis of hyperprolactinemia treated by soothing the liver. Asia Pac Tradit Med  2020,16(01),168-172","journal-title":"Asia Pac Tradit Med"},{"key":"ref=55","first-page":"70","volume":"25","author":"Zhang F.","year":"2019","unstructured":"Zhang F.; Chen J.; Xu L.; Li Y.; Effect of modified Xiaoyaosan on ERK signal transduction pathway of dopamine receptorin model rats with hyperprolactinemia. Zhongguo Shiyan Fangjixue Zazhi  2019,25(15),70-76","journal-title":"Zhongguo Shiyan Fangjixue Zazhi"},{"key":"ref=56","first-page":"3909","volume":"33","author":"Zhang T.","year":"2018","unstructured":"Zhang T.; Li Y.; Xu L.; Yang R.; Li X.; Ling X.; Effects of Xiaoyao Powder on the apoptosis of ovarian granule cells and related protein in HPRL model rats. Zhonghua Zhongyiyao Zazhi  2018,33(09),3909-3912","journal-title":"Zhonghua Zhongyiyao Zazhi"},{"key":"ref=57","first-page":"10","volume":"29","author":"Liu C.","year":"2019","unstructured":"Liu C.; Lai S.; Mechanism of Modified Danggui Shaoyao Powder in treating hyperprolactinemia rats based on dopamine receptorcAMP-PKA signaling pathway. Zhejiang J Integr Tradit Chin West Med  2019,29(01),10-15","journal-title":"Zhejiang J Integr Tradit Chin West Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"116361","DOI":"10.1016\/j.biopha.2024.116361","volume":"173","author":"Zhai S.Y.","year":"2024","unstructured":"Zhai S.Y.; Gu H.W.; Wang C.; Li Y.S.; Tang H.B.; Gynura procumbens and selected metabolites: Amelioration of depressive-like behaviors in mice and risperidone-induced hyperprolactinemia in rats. Biomed Pharmacother  2024,173,116361","journal-title":"Biomed Pharmacother"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.5114\/aoms.2020.98199","volume":"17","author":"Zhang N.","year":"2021","unstructured":"Zhang N.; Xu H.; Wang Y.; Yao Y.; Liu G.; Lei X.; Sun H.; Wu X.; Li J.; Protective mechanism of kaempferol against A\u03b225-35-mediated apoptosis of pheochromocytoma (PC-12) cells through the ER\/ERK\/MAPK signalling pathway. Arch Med Sci  2021,17(2),406-416","journal-title":"Arch Med Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/molecules27020333","volume":"27","author":"Kluska M.","year":"2022","unstructured":"Kluska M.; Juszczak M.; \u017buchowski J.; Stochmal A.; Wo\u017aniak K.; Effect of Kaempferol and its glycoside derivatives on antioxidant status of HL-60 cells treated with Etoposide. Molecules  2022,27(2),333","journal-title":"Molecules"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/foods11101505","volume":"11","author":"Kim E.H.","year":"2022","unstructured":"Kim E.H.; Shim Y.Y.; Lee H.I.; Lee S.; Reaney M.J.T.; Chung M.J.; Astragalin and isoquercitrin isolated from Aster scaber suppress LPS-induced neuroinflammatory responses in microglia and mice. Foods  2022,11(10),1505","journal-title":"Foods"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"10345","DOI":"10.1080\/21655979.2021.1996317","volume":"12","author":"Cao Y.","year":"2021","unstructured":"Cao Y.; Chen Y.; Wang P.; Lu J.; Han X.; She J.; Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency. Bioengineered  2021,12(2),10345-10362","journal-title":"Bioengineered"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"113849","DOI":"10.1016\/j.yexcr.2023.113849","volume":"433","author":"Liu H.","year":"2023","unstructured":"Liu H.; Huang Y.; Yang J.; Xu X.; Dai Q.; Zhang Y.; Zhao L.; Zhang M.; Zhang J.; Liu T.; Zhong L.; Involvement of estrogen receptor activation in kaempferol-3-O-glucoside\u2019s protection against aging-related cognition impairment and microglial inflammation. Exp Cell Res  2023,433(2),113849","journal-title":"Exp Cell Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12967-023-04048-z","volume":"21","author":"Ruan G.Y.","year":"2023","unstructured":"Ruan G.Y.; Ye L.X.; Lin J.S.; Lin H.Y.; Yu L.R.; Wang C.Y.; Mao X.D.; Zhang S.H.; Sun P.M.; An integrated approach of network pharmacology, molecular docking, and experimental verification uncovers kaempferol as the effective modulator of HSD17B1 for treatment of endometrial cancer. J Transl Med  2023,21(1),204","journal-title":"J Transl Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1002\/ptr.7067","volume":"35","author":"Harrath A.H.","year":"2021","unstructured":"Harrath A.H.; Jalouli M.; Oueslati M.H.; Farah M.A.; Feriani A.; Aldahmash W.; Aldawood N.; Al-Anazi K.; Falodah F.; Swelum A.; Alwasel S.; The flavonoid, KAEMPFEROL\u20103\u2010O\u2010APIOFURANOSYL\u20107\u2010O \u2010rhamnopyranosyl, as a potential therapeutic agent for breast cancer with a promoting effect on ovarian function. Phytother Res  2021,35(11),6170-6180","journal-title":"Phytother Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3390\/antiox11101912","volume":"11","author":"Bakrim S.","year":"2022","unstructured":"Bakrim S.; Benkhaira N.; Bourais I.; Benali T.; Lee L.H.; El Omari N.; Sheikh R.A.; Goh K.W.; Ming L.C.; Bouyahya A.; Health benefits and pharmacological properties of stigmasterol. Antioxidants  2022,11(10),1912","journal-title":"Antioxidants"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e301221199685","DOI":"10.2174\/1573407218666211230144036","volume":"18","author":"Yadav P.","year":"2022","unstructured":"Yadav P.; Chauhan C.; Singh S.; Banerjee S.; Murti K.; \u03b2-sitosterol in various pathological conditions: An update. Curr Bioact Compd  2022,18(6),e301221199685","journal-title":"Curr Bioact Compd"},{"key":"ref=68","first-page":"e59910716992","volume":"10","author":"Bernardi D.M.","year":"2021","unstructured":"Bernardi D.M.; Marchi J.P.; De Souza Alferes Ara\u00fajo C.; Nascimento V.R.D.; De Souza Lima D.; Wietzikoski S.; Ferro M.M.; Miyoshi E.; L\u00edvero F.A.D.R.; Seixas F.A.V.; Lovato E.C.W.; Dopamine docking studies of biologically active metabolites from Curcuma longa L. Research. Soc Dev  2021,10(7),e59910716992","journal-title":"Soc Dev"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jff.2017.12.059","volume":"42","author":"Lin Y.C.","year":"2018","unstructured":"Lin Y.C.; Liu L.C.; Ho C.T.; Hung C.M.; Way T.D.; Luteolin inhibits ER-\u03b1 expression through ILK inhibition is regulated by a pathway involving twist and YB-1. J Funct Foods  2018,42(42),75-84","journal-title":"J Funct Foods"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13058-022-01522-2","volume":"24","author":"Mintz R.","year":"2022","unstructured":"Mintz R.; Wang M.; Xu S.; Colditz G.A.; Markovic C.; Toriola A.T.; Hormone and receptor activator of NF-\u03baB (RANK) pathway gene expression in plasma and mammographic breast density in postmenopausal women. Breast Cancer Res  2022,24(1),28","journal-title":"Breast Cancer Res"},{"key":"ref=71","first-page":"434","volume":"13","author":"Sun J.W.","year":"2019","unstructured":"Sun J.W.; Collins J.M.; Ling D.; Wang D.; Highly variable expression of ESR1 splice variants in human liver: Implication in the liver gene expression regulation and inter-person variability in drug metabolism and liver related diseases. J Mol Genet Med  2019,13(3),434","journal-title":"J Mol Genet Med"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"S331","DOI":"10.1016\/j.euroneuro.2020.09.427","volume":"40","author":"Ivanova S.A.","year":"2020","unstructured":"Ivanova S.A.; Paderina D.Z.; Boiko A.S.; Pozhidaev I.V.; Kornetova E.G.; Wilffert B.; Loonen A.J.M.P.; 583 Polymorphisms in BDNF, AKT1, GSK3B genes: Possible association with antipsychotic-induced hyperprolactinemia in schizophrenia patients. Eur Neuropsychopharmacol  2020,40,S331-S332","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1071\/RD15553","volume":"29","author":"Arias-\u00c1lvarez M.","year":"2017","unstructured":"Arias-\u00c1lvarez M.; Garc\u00eda-Garc\u00eda R.M.; L\u00f3pez-Tello J.; Rebollar P.G.; Guti\u00e9rrez-Ad\u00e1n A.; Lorenzo P.L.; In vivo and in vitro maturation of rabbit oocytes differently affects the gene expression profile, mitochondrial distribution, apoptosis and early embryo development. Reprod Fertil Dev  2017,29(9),1667-1679","journal-title":"Reprod Fertil Dev"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"Glaviano A.","year":"2023","unstructured":"Glaviano A.; Foo A.S.C.; Lam H.Y.; Yap K.C.H.; Jacot W.; Jones R.H.; Eng H.; Nair M.G.; Makvandi P.; Geoerger B.; Kulke M.H.; Baird R.D.; Prabhu J.S.; Carbone D.; Pecoraro C.; Teh D.B.L.; Sethi G.; Cavalieri V.; Lin K.H.; Javidi-Sharifi N.R.; Toska E.; Davids M.S.; Brown J.R.; Diana P.; Stebbing J.; Fruman D.A.; Kumar A.P.; PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer  2023,22(1),138","journal-title":"Mol Cancer"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"130782","DOI":"10.1016\/j.ijbiomac.2024.130782","volume":"264","author":"Lang L.","year":"2024","unstructured":"Lang L.; Liang S.; Zhang F.; Fu Y.; Wang J.; Deng K.; Wang L.; Gao P.; Zhu C.; Shu G.; Wu R.; Jiang Q.; Wang S.; Knockdown of the VEGFB\/VEGFR1 signaling suppresses pubertal mammary gland development of mice via the inhibition of PI3K\/Akt pathway. Int J Biol Macromol  2024,264(Pt 2),130782","journal-title":"Int J Biol Macromol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.3390\/foods13172813","volume":"13","author":"Chen J.","year":"2024","unstructured":"Chen J.; Pan Z.; Li Q.; Wu Y.; Li X.; Wang X.; Hao D.; Peng X.; Pan L.; Li W.; Wang J.; Li T.; Fu F.; The aqueous extract of Hemerocallis citrina Baroni improves the lactation-promoting effect in bovine mammary epithelial cells through the PI3K-AKT signaling pathway. Foods  2024,13(17),2813","journal-title":"Foods"},{"key":"ref=77","first-page":"270","volume":"55","author":"Yang J.","year":"2023","unstructured":"Yang J.; Du J.; Wang Y.X.; Liu C.R.; Activation of JAK\/STAT in ovarian high-grade serous cancers and its prognostic significance. Beijing Da Xue Xue Bao  2023,55(2),270-275","journal-title":"Beijing Da Xue Xue Bao"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/j.1460-2075.1996.tb00361.x","volume":"15","author":"Braun T.","year":"1996","unstructured":"Braun T.; Arnold H.H.; Myf-5 and myoD genes are activated in distinct mesenchymal stem cells and determine different skeletal muscle cell lineages. EMBO J  1996,15(2),310-318","journal-title":"EMBO J"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/jcb.20316","volume":"94","author":"Takayanagi H.","year":"2005","unstructured":"Takayanagi H.; Kim S.; Koga T.; Taniguchi T.; Stat1-mediated cytoplasmic attenuation in osteoimmunology. J Cell Biochem  2005,94(2),232-240","journal-title":"J Cell Biochem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1101\/gad.11.2.179","volume":"11","author":"Liu X.","year":"1997","unstructured":"Liu X.; Robinson G.W.; Wagner K.U.; Garrett L.; Wynshaw-Boris A.; Hennighausen L.; Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev  1997,11(2),179-186","journal-title":"Genes Dev"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-024-01524-x","volume":"17","author":"Zhang H.","year":"2024","unstructured":"Zhang H.; Liu Y.; Liu J.; Chen J.; Wang J.; Hua H.; Jiang Y.; cAMP-PKA\/EPAC signaling and cancer: The interplay in tumor microenvironment. J Hematol Oncol  2024,17(1),5","journal-title":"J Hematol Oncol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/cells11020308","volume":"11","author":"Aslam M.","year":"2022","unstructured":"Aslam M.; Ladilov Y.; Emerging role of cAMP\/AMPK signaling. Cells  2022,11(2),308","journal-title":"Cells"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.4314\/tjpr.v15i9.13","volume":"15","author":"Miao H.","year":"2016","unstructured":"Miao H.; Miao C.; Han J.; Li N.; Anti-hyperprolactinemia mechanism of Radix bupleuri extract in rats. Trop J Pharm Res  2016,15(9),1903-1907","journal-title":"Trop J Pharm Res"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099366667250410061157","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/241537\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099366667250410061157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:14:53Z","timestamp":1785989693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/241537\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734099366667250410061157","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}